The politics of hormone replacement therapy.
This issue of the International Journal of Pharmaceutical Compounding includes several articles about hormone replacement therapy. Some of those articles are similar in content, but they have an important message in common: Patients, physicians, and compounding pharmacists should not be swayed by the misconceptions about compounding prescriptions for patients requiring hormone replacement therapy, nor should they be influenced by misinformation about the profession of pharmaceutical compounding. The pharmaceutical industry drives and funds both the legislative control and minimization of pharmacy compounding and, by disseminating misinformation and presenting biased viewpoints, openly discourages compounding. Political activists are working for both sides-for the pharmaceutical industry and for the profession of comounding-and such politics will continue for many years.